- freely available
The Dynamics of Autism Spectrum Disorders: How Neurotoxic Compounds and Neurotransmitters Interact
AbstractIn recent years concern has risen about the increasing prevalence of Autism Spectrum Disorders (ASD). Accumulating evidence shows that exposure to neurotoxic compounds is related to ASD. Neurotransmitters might play a key role, as research has indicated a connection between neurotoxic compounds, neurotransmitters and ASD. In the current review a literature overview with respect to neurotoxic exposure and the effects on neurotransmitter systems is presented. The aim was to identify mechanisms and related factors which together might result in ASD. The literature reported in the current review supports the hypothesis that exposure to neurotoxic compounds can lead to alterations in the GABAergic, glutamatergic, serotonergic and dopaminergic system which have been related to ASD in previous work. However, in several studies findings were reported that are not supportive of this hypothesis. Other factors also might be related, possibly altering the mechanisms at work, such as time and length of exposure as well as dose of the compound. Future research should focus on identifying the pathway through which these factors interact with exposure to neurotoxic compounds making use of human studies.
Share & Cite This Article
Export to BibTeX | EndNote
MDPI and ACS Style
Quaak, I.; Brouns, M.R.; Van de Bor, M. The Dynamics of Autism Spectrum Disorders: How Neurotoxic Compounds and Neurotransmitters Interact. Int. J. Environ. Res. Public Health 2013, 10, 3384-3408.View more citation formats
Quaak I, Brouns MR, Van de Bor M. The Dynamics of Autism Spectrum Disorders: How Neurotoxic Compounds and Neurotransmitters Interact. International Journal of Environmental Research and Public Health. 2013; 10(8):3384-3408.Chicago/Turabian Style
Quaak, Ilona; Brouns, Madeleine R.; Van de Bor, Margot. 2013. "The Dynamics of Autism Spectrum Disorders: How Neurotoxic Compounds and Neurotransmitters Interact." Int. J. Environ. Res. Public Health 10, no. 8: 3384-3408.
- Supplementary File 1:
Supplementary (PDF, 173 KB)